Acute angle closure glaucoma (AACG) is a rare complication of carotid-cavernous fistula (CCF). However, rarer is iatrogenic AACG subsequent to CCF's standard treatment, endovascular embolization. To our knowledge, this is the first case in which AACG after angiography (a failed attempt at embolization) is treated primarily with embolization, and the first case of AACG and CCF that has yielded such a successful visual recovery.
View Article and Find Full Text PDFBackground: In Canada, public drug plans may restrict the use of newer topical antiglaucoma agents. The goals of this retrospective study were to estimate the proportion of patients who, at the initiation of topical glaucoma therapy, had contraindications to the use of topical beta-blockers and to identify whether changes in formulary listing status (from restricted-drug list to generally available drug list) influenced the use of topical glaucoma agents in patients with contraindications to beta-blockers.
Methods: Claims databases administered by the Régie de l'assurance maladie du Quebec were used to identify incident users of beta-blockers (betaxolol and timolol) and newer antiglaucoma agents (brimonidine, dorzolamide and latanoprost) among patients aged 35 years or older.
Am J Ophthalmol
December 2000
Purpose: To describe 2 cases of long-term successful clinical outcome after goniosynechialysis for secondary angle-closure glaucoma after vitreoretinal surgery.
Methods: Case reports. Goniosynechialysis was performed bilaterally in 1 patient and unilaterally in another for uncontrolled angle-closure glaucoma after vitreoretinal surgery.
Objective: To determine the chemical stability of various mitomycin C (MMC) solutions used in glaucoma filtering surgery.
Methods: A survey of the MMC solutions currently in use in 21 hospitals (11 in Canada, 10 in the United States) was conducted. A comparative study of the chemical stability of five different representative solutions was performed.